The call ran from 11:01 AM to 12:05 PM IST (1 h 4 min).
Key takeaways
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
| Revenue: guided vs achieved | 25.00% achieved Guided 15.00%–20.00%, 25.0% above the top of the range; confirmed by management |
|---|---|
| Revenue guidance | 17.5% → 20.0% Raised by 2.5 percentage points |
| Management target | Revenue 20.0% FY27 |
| Revenue growth | 26.7% YoY growth, driven by 16.5% volume and higher radiology mix. |
|---|---|
| Margins | EBITDA margin expanded 350 bps to 44.1% due to operating leverage. |
| Demand visibility | Strong underlying demand for quality diagnostics; high-end radiology seeing robust traction. |
| Management confidence | High; management emphasized sustainable momentum across both core and new markets. |
Growth
Consolidated revenue grew 26.7% YoY, primarily volume-led (16.5%) with a favorable shift toward high-end radiology tests and a 3% boost from CGHS tariff revisions.
Outlook
Management raised revenue guidance to at least 20% for FY27, citing strong H1 momentum and network ramp-up.
Risks
High geographic concentration in Hyderabad (67% revenue) and potential execution risks in newer markets like Kolkata and Pune.
Last quarter's promises, checked
Delivered
- FY27 'high double digit' → Q2 rev +26.7% YoY, FY27 raised to ≥20% (= BEAT)
- EBITDA margin 'above 40%' → 44.1% (= BEAT)
- Surplus cash ~₹330 Cr → ₹355 Cr (= BEAT)
Partly delivered
- 9 hubs in 12 mo → 8 hubs by Q1 FY28 (= PARTIAL)
- Capex ₹190–195 Cr → ₹155–160 Cr for 8 hubs (= PARTIAL)
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
FY27 capex of ₹140-150cr for 4-5 hubs and 10-12 spokes; targeting 40%+ EBITDA margins.
Growth they described
FY26 revenue grew 19.5% YoY to ₹814cr; Q4 PAT grew 37.5% YoY to ₹47.9cr with 43.5% EBITDA margin.
Call details
| Company | Vijaya Diagnostic Centre Ltd |
|---|---|
| NSE symbol | VIJAYA |
| ISIN | INE043W01024 |
| Call | Q2 FY27 earnings call |
| Date | Wednesday, 4 November 2026 |
| Time | 11:00 AM IST |
| Length | 1 h 4 min |
| Audio | Our stream on YouTube ↗ |
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,425.00
- Market cap
- ₹14,677 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 72.1×Sector 53.8×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Wed, 4 Nov
Today's concalls →
